Search

Results for "Immunotherapy"

Technology Innovation Institute, Burjeel Medical City Partner to Advance Immunotherapy Solutions for Cancer Patients

TII · Mar 17

Technology Innovation Institute (TII) and Burjeel Medical City (BMC) are partnering to develop novel immunotherapy solutions for cancer treatment, focusing on T-cell based therapeutics like CAR-T and TIL therapy. In the first phase, TII will construct a computational platform to identify patient-specific antigens from single-cell transcriptomics data, enabling the design of CAR-T cells. The two-year partnership aims to boost the body's immune system to fight cancer and personalize cancer therapies using TII's technologies. Why it matters: This collaboration signifies the UAE's commitment to advancing cancer care through collaborative research and innovative solutions, potentially establishing the country as a leader in personalized oncology treatments.

KAUST welcomes 2025 Ibn Rushd Postdoctoral Fellows, strengthening Saudi research talent

KAUST · Feb 6

KAUST has announced the 2025 cohort of Ibn Rushd Postdoctoral Fellows, a program designed to strengthen Saudi Arabia's research ecosystem. The fellows, including Abdullah Hassan Bukhamsin and Akram Alwithenani, will pursue postdoctoral work at institutions like Caltech and Harvard. Bukhamsin's research focuses on minimally invasive sensors for environmental and agricultural applications, while Alwithenani specializes in cancer gene and immunotherapy. Why it matters: This program is crucial for developing Saudi research talent and aligning with the Kingdom's Vision 2030 goals in science and technology.